Robyn Scatena, MD
About
Biography
Robyn completed her internal medicine residency and pulmonary and critical care fellowship at Yale and joined faculty in 2012. She spends her time caring for patients and teaching residents and fellows in the medical intensive care unit and in the Winchester clinic. She is a member of the Yale Center for Asthma and Airways Disease and Yale Adult Cystic Fibrosis teams, and sees general pulmonary patients as well.
Appointments
Pulmonary, Critical Care & Sleep Medicine
Assistant Clinical ProfessorPrimary
Other Departments & Organizations
Education & Training
- Fellow
- Yale (2012)
- Internship and Residency
- Yale (2009)
- MD
- University of California at Davis School of Medicine (2006)
- BS
- Harvard University, Cognitive Neuroscience (2002)
Research
Research at a Glance
Publications Timeline
A big-picture view of Robyn Scatena's research output by year.
4Publications
4Citations
Publications
2024
New-onset Diffuse Alveolar Hemorrhage in Setting of Mycobacterium Avium Complex in an Elderly Patient
Fan H, Jansen D, Acott B, Scatena R. New-onset Diffuse Alveolar Hemorrhage in Setting of Mycobacterium Avium Complex in an Elderly Patient. 2024, a6300-a6300. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6300.Peer-Reviewed Original ResearchCitations
2023
Infliximab-induzierte unspezifische interstitielle Pneumonitis bei einem Patienten mit Colitis ulcerosa
Nasir S, Patel R, Wojkiewicz S, Scatena R. Infliximab-induzierte unspezifische interstitielle Pneumonitis bei einem Patienten mit Colitis ulcerosa. Kompass Autoimmun 2023, 5: 92-95. DOI: 10.1159/000530555.Peer-Reviewed Original ResearchAltmetric
2022
Infliximab-Induced Non-specific Interstitial Pneumonitis in a Patient With Ulcerative Colitis (UC)
Nasir S, Patel R, Wojkiewicz S, Scatena R. Infliximab-Induced Non-specific Interstitial Pneumonitis in a Patient With Ulcerative Colitis (UC). Cureus 2022, 14: e33064. PMID: 36721597, PMCID: PMC9883057, DOI: 10.7759/cureus.33064.Peer-Reviewed Original ResearchCitationsConceptsNon-specific interstitial pneumonitisInterstitial lung diseaseInflammatory bowel diseaseTumor necrosis factorUlcerative colitisInterstitial pneumonitisAdverse effects of infliximabInfections due to immunosuppressionModerate to severe inflammatory bowel diseaseFamily of tumor necrosis factorSevere inflammatory bowel diseaseHigh dose steroidsEffect of infliximabInflammatory bowel disease patientsConnective tissue disordersDose steroidsHistological remissionInfliximab infusionLung biopsyRare complicationLung findingsPulmonary statusRespiratory statusTissue disordersAlpha inhibitors
2020
Continuous Intravenous Flumazenil Infusion Used in Iatrogenic Chlordiazepoxide Overdose in the Setting of Alcoholic Withdrawal Syndrome Management
Volney G, Scatena R. Continuous Intravenous Flumazenil Infusion Used in Iatrogenic Chlordiazepoxide Overdose in the Setting of Alcoholic Withdrawal Syndrome Management. Cureus 2020, 12: e10648. PMID: 33133818, PMCID: PMC7586353, DOI: 10.7759/cureus.10648.Peer-Reviewed Original ResearchCitationsConceptsAlcohol withdrawal syndromeFlumazenil infusionWithdrawal syndromeBenzodiazepine overdoseAWS managementTreatment of alcohol withdrawal syndromeConcomitant medical conditionsBenzodiazepine receptor sitesSyndromic managementContinuous infusionCompetitive antagonistDelayed metabolismInfusionBenzodiazepinesReceptor sitesMedical conditionsOverdoseFlumazenilChlordiazepoxideTreatment
Get In Touch
Contacts
Academic Office Number
Appointment Number
Office Fax Number
Clinic Fax Number
Mailing Address
Pulmonary, Critical Care & Sleep Medicine
15 York Street
New Haven, CT 06510
United States